Quince Therapeutics QNCX
NASDAQ QNCX
$28.96 -1.36 (-4.47%)
At close: Sep 10, 2026 · 4:00 PM EDT

Quince Therapeutics (QNCX) Exchange Rate Effect (2021 - 2026)

Quince Therapeutics (QNCX) posted Exchange Rate Effect of -$229000.0 for Q2 2026, up 84.34% on a QoQ basis from -$1.5 million in Q1 2026, and down 1305.26% year-over-year from $19000.0 in Q2 2025.

Analysis

Quince Therapeutics (QNCX) Exchange Rate Effect (2021 - 2026) Analysis & Trends

Quince Therapeutics has reported Exchange Rate Effect for 6 years, with the latest figure at -$229000.0 in Q2 2026.

  • On a quarterly basis, Exchange Rate Effect fell 1305.26% year-over-year to -$229000.0 in Q2 2026; TTM through Jun 2026 was -$2.0 million, a 661.52% decrease from a year earlier, with the FY2025 full-year figure at -$114000.0, down 149.35% from the prior year.
  • Exchange Rate Effect was -$229000.0 for Q2 2026 at Quince Therapeutics, up from -$1.5 million in the prior quarter.
  • The five-year high for Exchange Rate Effect was $409000.0 in Q3 2022, with the low at -$1.5 million in Q1 2026.
  • Average Exchange Rate Effect over 5 years is -$72777.8, with a median of -$42000.0 recorded in 2022.
  • The sharpest annual moves came in 2022 and 2026: Exchange Rate Effect soared 1310.34% in 2022, then tumbled 1305.26% in 2026.
  • Over 5 years, Exchange Rate Effect stood at -$43000.0 in 2022, then sank by 479.07% to -$249000.0 in 2023, then jumped by 189.16% to $222000.0 in 2024, then plunged by 220.27% to -$267000.0 in 2025, then rose by 14.23% to -$229000.0 in 2026.
  • The last three Exchange Rate Effect figures came in at -$229000.0 (Q2 2026), -$1.5 million (Q1 2026), and -$267000.0 (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Exchange Rate Effect (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn -
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn -19.00 Mn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn -3.70 Mn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn -300,000.00
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn -
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn -2.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn -2.45 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn -3.40 Mn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn 315,000.00
10 Quince Therapeutics 175.52 Mn 175.52 Mn - -229,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -229,000.00
Mar 31, 2026 -1.46 Mn
Dec 31, 2025 -267,000.00
Sep 30, 2025 -41,000.00
Jun 30, 2025 19,000.00
Mar 31, 2025 175,000.00
Dec 31, 2024 222,000.00
Sep 30, 2024 -60,000.00
Jun 30, 2024 -241,000.00
Mar 31, 2024 310,000.00
Dec 31, 2023 -249,000.00
Sep 30, 2023 155,000.00
Jun 30, 2023 60,000.00
Mar 31, 2023 114,000.00
Dec 31, 2022 -43,000.00
Sep 30, 2022 409,000.00
Jun 30, 2022 -78,000.00
Mar 31, 2022 -104,000.00
Dec 31, 2021 26,000.00
Sep 30, 2021 29,000.00